Critics have raised concerns regarding a study on cross-sex hormone regret rates, citing potential issues with missing data and the reporting of individuals who discontinued treatment.
Coverage spectrum
Read at your length
Critics have raised concerns regarding a study on cross-sex hormone regret rates, citing potential issues with missing data and the reporting of individuals who discontinued treatment.
The Post reported the reassuring percentages while failing to examine the missing responses and the considerably higher regret rate among those who discontinued treatment.
Conservative Review reported the story as "WaPo Ignores Huge Errors In Study Claiming 97 Percent Of Opposite-Sex Hormone-Takers Have No Regrets."
2 sources have covered this story, including Conservative Review and The Federalist. The earliest reporting in the cluster landed about 13 hours ago.
How each side is reporting it
How the left is reporting it
How the wires + center are reporting it
How it spread
Left 0Center 0Right 2No left or center outlets yet.
Time since the first report
Who carried it, in order
- FirstConservative ReviewNov 13, 7:35 AM ET · United StatesRight
- +0mThe FederalistNov 13, 7:35 AM ET · United StatesRight
Claim ledger
[01] VerifiedCore event reported by 2 independent outlets across the spectrum.
[02] DisputedKey facts present in mainstream desks; corroboration thin from wires.